rethinkTHC Search
Menu
Study breakdown

Higher endocannabinoid levels appeared to buffer the link between childhood trauma and inflammation in people with borderline personality disorder

Cross SectionalPreliminary evidence
The takeaway

In a study of 48 women with borderline personality disorder and 31 healthy controls, higher endocannabinoid levels appeared to weaken the association between adverse childhood experiences and the inflammatory marker IL-6.

Trauma researchers, mental health professionals treating BPD, and scientists studying the endocannabinoid system's role in stress and inflammation.

Trauma-inflammation link absent in those with highest endocannabinoid levels

What the researchers found

People with BPD had higher IL-6 levels than healthy controls. Endocannabinoids (AEA and 2-AG) correlated positively with IL-6 across all participants. The link between childhood trauma and IL-6 was strongest in participants with low endocannabinoid levels, while those with the highest endocannabinoid levels showed no correlation between trauma and inflammation.

Why it matters

This study connects three systems rarely examined together: childhood trauma, the immune system, and the endocannabinoid system. The finding that endocannabinoids may buffer the trauma-inflammation link suggests a potential mechanism for why some trauma survivors develop inflammatory conditions and others do not.

The numbers in context

48 females with BPD and 31 healthy controls. Higher IL-6 in BPD group. AEA and 2-AG positively correlated with IL-6. Trauma-IL-6 correlation strong in lowest three endocannabinoid quartiles (n=57) but absent in highest quartile (n=19). Recent suicide attempts significantly higher in high-IL-6 group (OR=0.22).

How the study worked

Cross-sectional analysis of 48 females with borderline personality disorder and 31 matched healthy controls. Adverse childhood experiences were assessed via the Childhood Trauma Questionnaire. Plasma IL-6, anandamide (AEA), and 2-AG concentrations were measured.

What this study cannot tell us

Cross-sectional design cannot establish causality. Female-only sample. Small sample sizes, especially in subgroup analyses. Single time-point measurements of endocannabinoids and IL-6 may not capture dynamic fluctuations.

How to read the evidence

Preliminary: small cross-sectional study with female-only sample and exploratory subgroup analyses.

When this study was published

Published 2026.

The bigger picture

The endocannabinoid system is increasingly recognized as a stress buffer. This study provides human evidence that endocannabinoids may modulate how childhood adversity translates into adult inflammation, with implications for both trauma recovery and mental health treatment.

Questions still open

  • Could endocannabinoid-boosting interventions reduce inflammation in trauma survivors? Do these patterns hold in males with BPD? Is the suicide-IL-6 association a direct pathway or confounded by other factors?

Common questions

Can the endocannabinoid system protect against trauma-related inflammation?
This study found that people with the highest endocannabinoid levels showed no correlation between childhood trauma and the inflammatory marker IL-6, while those with lower levels showed a strong link.
Is inflammation linked to suicide risk in BPD?
In this study, the number of recent suicide attempts was significantly higher among those with elevated IL-6 levels, though the study cannot establish whether inflammation directly contributes to suicide risk.

Read the original research

The role of the endocannabinoid system in the interplay of adverse childhood experiences and interleukin 6 in individuals with borderline personality disorder.

Psychopharmacology, 243(2), 315-324

Citation

Spohrs, Jennifer; Kühnle, Valentin; Reber, Stefan O; Mikusky, David; Sanhüter, Niklas; Macchia, Ana; Nickel, Sandra; Abler, Birgit. (2026). The role of the endocannabinoid system in the interplay of adverse childhood experiences and interleukin 6 in individuals with borderline personality disorder.. Psychopharmacology, 243(2), 315-324. https://doi.org/10.1007/s00213-025-06809-8

Explore the wider topic